Optimax Holdings Sdn Bhd (0222) - Total Liabilities

Latest as of September 2025: RM64.64 Million MYR ≈ $16.23 Million USD

Based on the latest financial reports, Optimax Holdings Sdn Bhd (0222) has total liabilities worth RM64.64 Million MYR (≈ $16.23 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Optimax Holdings Sdn Bhd generate cash to assess how effectively this company generates cash.

Optimax Holdings Sdn Bhd - Total Liabilities Trend (2016–2024)

This chart illustrates how Optimax Holdings Sdn Bhd's total liabilities have evolved over time, based on quarterly financial data. Check Optimax Holdings Sdn Bhd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Optimax Holdings Sdn Bhd Competitors by Total Liabilities

The table below lists competitors of Optimax Holdings Sdn Bhd ranked by their total liabilities.

Company Country Total Liabilities
Vakrangee Limited
NSE:VAKRANGEE
India Rs1.25 Billion
DMCC SPECIALITY CHEMICALS LIMITED
NSE:DMCC
India Rs1.41 Billion
Huadian Ener-B
SHG:900937
China $23.81 Billion
Transat AT Inc
TO:TRZ
Canada CA$3.22 Billion
PolyPid
NASDAQ:PYPD
USA $11.33 Million
Vinyl Group Ltd
AU:VNL
Australia AU$5.15 Million
Aerovate Therapeutics Inc
NASDAQ:AVTE
USA $2.49 Million
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762
Taiwan NT$1.23 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Optimax Holdings Sdn Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Optimax Holdings Sdn Bhd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.98 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.92 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.86 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.44 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Optimax Holdings Sdn Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Optimax Holdings Sdn Bhd (2016–2024)

The table below shows the annual total liabilities of Optimax Holdings Sdn Bhd from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 RM75.34 Million
≈ $18.91 Million
+45.49%
2023-12-31 RM51.78 Million
≈ $13.00 Million
+31.43%
2022-12-31 RM39.40 Million
≈ $9.89 Million
+12.98%
2021-12-31 RM34.87 Million
≈ $8.76 Million
+2.53%
2020-12-31 RM34.01 Million
≈ $8.54 Million
-14.27%
2019-12-31 RM39.68 Million
≈ $9.96 Million
+12.10%
2018-12-31 RM35.40 Million
≈ $8.89 Million
+47.89%
2017-12-31 RM23.93 Million
≈ $6.01 Million
+18.43%
2016-12-31 RM20.21 Million
≈ $5.07 Million
--

About Optimax Holdings Sdn Bhd

KLSE:0222 Malaysia Medical Care Facilities
Market Cap
$77.75 Million
RM309.68 Million MYR
Market Cap Rank
#20180 Global
#376 in Malaysia
Share Price
RM0.57
Change (1 day)
+1.79%
52-Week Range
RM0.50 - RM0.70
All Time High
RM0.82
About

Optimax Holdings Berhad, an investment holding company, engages in the provision of eye specialist services and related products in Malaysia. The company's specialist centers offer a range of treatments relating to eye diseases, such as cataracts, glaucoma, conjunctivitis, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye d… Read more